Kolexia
Lachot Sebastien
Biologie médicale
Centre hospitalier de Tours
Tours, France
28 Activités
35 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Syndromes myélodysplasiques Microangiopathies thrombotiques Hypertension artérielle Syndrome hémolytique et urémique Défaillance cardiaque Atteinte rénale aigüe Syndrome coronarien aigu Purpura Lymphome malin non hodgkinien

Industries

Janssen
2 collaboration(s)
Dernière en 2022
Sanofi
1 collaboration(s)
Dernière en 2023
Celgene
1 collaboration(s)
Dernière en 2020
Novartis
1 collaboration(s)
Dernière en 2022

Dernières activités

Modulation of bone marrow and peripheral blood cytokine levels by age and clonal hematopoiesis in healthy individuals.
Clinical immunology (Orlando, Fla.)   09 août 2023
01. Hématopoïèse et oncogenèse
Hématologie Congress 2022   30 mars 2022
Infection in Patients with Suspected Thrombotic Microangiopathy Based on Clinical Presentation.
Clinical journal of the American Society of Nephrology : CJASN   31 janvier 2022
What is the impact of blood pressure on neurological symptoms and the risk of ESKD in primary and secondary thrombotic microangiopathies based on clinical presentation: a retrospective study.
BMC nephrology   20 janvier 2022
Reference Values of Human Bone Marrow and Peripheral Blood Levels of 49 Cytokines According to Age and Clonal Hematopoiesis
Blood   23 novembre 2021
High prevalence of clonal hematopoiesis in the blood and bone marrow of healthy volunteers.
Blood advances   14 mai 2021
Automated Early Detection of Myelodysplastic Syndrome within the General Population Using the Research Parameters of Beckman-Coulter DxH 800 Hematology Analyzer.
Cancers   21 janvier 2021
Bone marrow oxidative stress and specific antioxidant signatures in myelodysplastic syndromes.
Blood advances   15 septembre 2020
Reactive oxygen species levels differentiate CD34 human progenitors based on CD38 expression.
Cytometry. Part B, Clinical cytometry   04 septembre 2020
Multicentric MFI30 study: Standardization of flow cytometry analysis of CD30 expression in non-Hodgkin lymphoma.
Cytometry. Part B, Clinical cytometry   17 août 2020